Safety and CSF distribution of high-dose erlotinib and...

  • Main
  • 2020 / 6
  • Safety and CSF distribution of high-dose erlotinib and...

Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non–small cell lung cancer (NSCLC) with brain metastases

Shriyan, Bharati, Patil, Deepali, Gurjar, Murari, Nookala, Manjunath, Patil, Anand, Kannan, Sadhana, Patil, Vijay, Joshi, Amit, Noronha, Vanita, Prabhash, Kumar, Gota, Vikram
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-020-02926-9
Date:
June, 2020
File:
PDF, 1.01 MB
2020
Conversion to is in progress
Conversion to is failed